baber/WOPTO huggingface dataset:
Patent EP-2342659-A2 (EP)
Title: Onglets combinables pour interface de documents a onglets
Inventor: SCOTT MATTHEW R
IPC: G06F3/14
Filed: 2009-11-03
Abstract: L'invention concerne un procédé et un système destinés à combiner des onglets d'une interface de document à onglets. Un système d'interface de documents à onglets combinables permet de combiner des onglets d'une interface de documents à onglets combinables pour former un onglet unique de ladite interface. Pour combiner les onglets, ce système génère un nom d'onglet combiné à partir des noms des onglets à combiner, ainsi qu'un contenu d'onglet combiné à partir du contenu des onglets à combiner. Si la largeur du contenu est supérieure à ce qui peut être affiché à ce moment là dans la fenêtre, le système d'interface peut ajouter une barre de défilement à l'interface de sorte que l'utilisateur puisse faire défiler et rendre visibles des parties du contenu qui étaient invisibles auparavant. Le système d'interface de documents à onglets combinables affiche ensuite l'onglet combiné et élimine les onglets qui ont été combinés. Le système selon l'invention permet également à un utilisateur de séparer un onglet combiné en onglets distincts.
Patent EP-2353073-A2 (EP)
Title: Isolement de données reçues sur un dispositif verrouillé
Inventor: WEBER KARON A
IPC: H04M1/67
Filed: 2009-11-17
Abstract: L'invention concerne la mise en quarantaine de données reçues pendant qu'un dispositif informatique est verrouillé. Pendant que le dispositif informatique est verrouillé, des articles de contenu tels que des images, des notifications, des mémorandums vocaux, des numéros de téléphone et analogue sont stockés dans une première zone de mémoire. Ces articles de contenu sont transférés vers une deuxième zone de mémoire, séparée de la première, sur la base de critères de transfert associés aux articles de contenu. Par exemple, des images peuvent être automatiquement téléchargées vers l'amont vers une page web une fois que le dispositif informatique est déverrouillé, et un programme de messagerie est exécuté pour afficher les messages reçus pendant que le dispositif informatique était verrouillé. Dans certaines formes de réalisation, l'utilisateur introduit les articles de contenu dans un dispositif informatique mobile verrouillé, et fournit ensuite des critères de transfert concernant ces articles de contenu.
Patent EP-2277907-A2 (EP)
Inventor: SAHIN UGUR
IPC: C12N15/113
Filed: 2003-03-12
Abstract: A pharmaceutical composition containing an agent (A) that: (a) inhibits expression or activity of a tumor-associated antigen (TAg); (b) has selective tumor-inhibiting activity against cells with (abnormal) expression of TAg; or (c) increases the amount of complex formed between an HLA (human leukocyte antigen) molecule and TAg, or its fragment, is new. A pharmaceutical composition containing an agent (A) that: (a) inhibits expression or activity of a tumor-associated antigen (TAg); (b) has selective tumor-inhibiting activity against cells with (abnormal) expression of TAg; or (c) increases the amount of complex formed between an HLA (human leukocyte antigen) molecule and TAg, or its fragment. TAg is encoded by nucleic acid (NA) that: (a) comprises any of 28 defined sequences given in the specification, or their fragments; (b) can hybridize to (a) under stringent conditions; (c) is a degenerate version of (a) or (b); or (d) is complementary to (a)-(c). Independent claims are also included for: (1) a pharmaceutical composition containing one or more of TAg, NA encoding TAg, antibody that binds to TAg, antisense sequences specific for NA, host cells that express TAg, or isolated complex of TAg with an HLA molecule (TAg may always by a fragment); (2) diagnosing diseases associated with (abnormal) expression of TAg (M1); (3) determining regression, progression or outbreak of diseases associated with (abnormal) expression of TAg (M2); (4) treating diseases associated with (abnormal) expression of TAg (M3); (5) NA as new compounds; (6) a nucleic acid (NA1) that encodes any of 35 specified peptide sequences or their fragments; (7) a recombinant DNA or RNA (NA2) that includes NA or NA1; (8) a host cell containing NA, NA1 or NA2; (9) proteins encoded by NA1 and their fragments that are immunogenic or can bind to HLA receptors or human antibodies; (10) agents (B) that bind specifically to a protein encoded by NA; (11) antibodies (Ab) that bind specifically to a complex of: (a) protein or its fragments encoded by NA; and (b) Major Histocompatibility (MHC) molecules to which (a) bind, but does not bind to (i) or (ii) singly; (12) a conjugate (C) between (B) or Ab and a diagnostic or therapeutic agent; (13) a kit for detecting (abnormal) expression of TAg; (14) recombinant DNA that includes a promoter region derived from NA; and (15) treatment, diagnosis and monitoring of metastatic cancer associated with (abnormal) expression of TPTE. ACTIVITY : Cytostatic. No biological data given. MECHANISM OF ACTION : Vaccine; Antisense/antibody inhibition of gene expression or activity.
Patent EP-2269449-A2 (EP)
Inventor: KOMEDA MASASHI
IPC: A01N1/02
Filed: 2003-08-29
Abstract: The present invention provides a composition for efficiently protecting and preserving organs, tissues or cells. In particular, the present invention provides a protective composition which can be used during operations. Specifically, the present invention provides a composition for protecting and preserving organs, tissues or cells, comprising a polyphenol. A method is also provided for protecting an organ, tissue or cell in a subject, comprising 1) exposing the organ, tissue or cell to a polyphenol. Such a composition and a polyphenol is effective in protecting a function of an organ (particularly, the heart, brain, nerve, spinal cord and the like).
Patent EP-2263781-A2 (EP)
Inventor: STREHLAU WOLFGANG
IPC: B01J21/12
Filed: 2005-04-14
Abstract: The present invention relates to an integrated system for the treatment of exhaust gases, which preferably consists of at least one NO x -storing component, at least one in situ ammonia-generating component, at least one ammonia-storing component and at least one ammonia (NH 3 )-SCR-component, as well as to a process for the treatment of exhaust gas comprising at least the steps (i) storing of NO x  under lean exhaust gas conditions in at least one NO x -storing component; (ii) in situ conversion of the stored NO x  to ammonia (NH 3 ) under rich exhaust gas conditions; (iii) storing of the ammonia (NH 3 ) in at least one NH 3 -storing component under rich exhaust gas conditions as well as the (iv) reaction of NH 3  with NO x  under lean exhaust gas conditions. Thereby, the partial steps "storing of NO x " and "conversion of NH 3  with NO x " are carried out at least partially and/or temporarily simultaneously and/or parallelly. Furthermore, preferred catalysts are disclosed for carrying out the process.
Patent EP-2173108-A2 (EP)
Inventor: KAWADA RYOICHI
IPC: H04N17/00
Filed: 2002-04-11
Abstract: A first characteristic value extracting unit (4) extracts a characteristic value from a picture transmitted from a transmission side (2), and a second characteristic value extracting unit (5) extracts a characteristic value from a picture received on a reception side (3). These extracted characteristic values are supplied to a central monitoring unit (8) through low speed lines (6), (7), respectively, In the central monitoring unit (8), an MSE (mean square error) is assessed from the data by an MSE assessing unit. The first and second characteristic value extracting units (4), (5) divide an input picture into blocks, subject the blocks to an orthogonal transformation, or subject the blocks to PN sequence multiplication before the orthogonal transformation, and extract and output orthogonal transformation coefficients. The MSE assessing unit (8a) determines the differences between corresponding coefficients on the transmission side and the reception side and squares the differences, adds the squared differences for every coefficients or every blocks, and assess an MSE based on the added values referred to a table. With this operation, the MSE can be effectively assessed using a smaller amount of extracted data (accordingly, slower speed lines can be used in the central monitoring unit (8)).
Patent EP-2216863-A2 (EP)
Inventor: SUZUKI AKIRA
IPC: H01T21/02
Filed: 2010-02-09
Abstract: A method for manufacturing a spark plug which includes: (a) preparing a metal shell; (b) preparing an insulator; (c) inserting the insulator in an insertion hole of the metal shell; (d) forming an intended crimping portion of the metal shell into a crimping portion; and (e) pressing a lower side portion of the metal shell closer to a position lower than the intended compressive deformation portion, and pressing the crimping portion of the metal shell in an axial direction to compressively deform the intended compressive deformation portion of the metal shell and thus seal a space between a stepped portion of the metal shell and a stepped portion of the insulator, wherein step (e) controls a pressing amount of a press in a constant value from the start of compressive deformation to the end thereof.
Patent EP-2226044-A2 (EP)
Inventor: WALDRIDGE IRENE A
IPC: A61H23/04
Filed: 2010-03-03
Abstract: A therapeutic compression garment is provided. The instant garment includes a unilateral torso structure, a biceps structure, and a tensioning structure. The unilateral torso structure comprises uniquely configured structure portions corresponding to front and rear panel forming elements. Contiguous perimeter segments of the uniquely configured structure portions delimit an armscye segment for the unilateral torso structure. The biceps structure is non-reversibly united, at a perimeter segment thereof, to the armscye segment of the unilateral torso structure. The tensioning structure selectively and reversibly unites portions of the unilateral torso structure.
Patent EP-2253683-A2 (EP)
Inventor: COPPUS STEFAN
IPC: B65D83/14
Filed: 2007-09-10
Abstract: A bonding method, using polyurethane (PU) foam supplied in cans (1), involves applying a strand (s) of foam to an adhesion substrate (3) to give an adhesive layer (4); allowing the foam to collapse so that only the desired adhesive layer remains; and pressing the component (5) to be bonded onto the substrate or adhesive layer. The PU foam sets within 0.5-30 (preferably 1-8) minutes of applying the foam strand. An independent claim is included for a set for carrying out a bonding operation, consisting of a PU foam spray container (1) and a liquid application device containing a bonding accelerator.
Patent EP-2282420-A2 (EP)
Inventor: MILLER MARK J
IPC: H04B7/185
Filed: 2010-07-09
Abstract: A method for determining attenuation settings across carriers in a return link bandwidth of a user terminal comprises determining a first attenuation setting for a user terminal at a first transmission frequency, where the first attenuation setting is based on a first signal quality metric value of a first message sent from the user terminal at the first transmission frequency. The method also comprises determining a second attenuation setting far the user terminal at a second transmission frequency, where the second attenuation setting is based on a second signal quality metric value of a second message sent from the user terminal at the second transmission frequency. The method also comprises determining the attenuation settings across the carriers in the return link bandwidth of the user terminal based on the first attenuation setting and the second attenuation setting.
Patent EP-2292824-A2 (EP)
Inventor: TOKURA MASASHI
IPC: D05C5/06
Filed: 2010-08-06
Abstract: In a sewing machine (1) that is included in a sewing system (100) that, using a plurality of the sewing machines, performs sewing of a single embroidery pattern on a work cloth (39) that is held by an embroidery frame (84, 384), at least one image is captured of at least one marker (180, 281, 282) that is positioned in a marker area (87, 88) (Step S15). A pattern condition and setting condition are acquired (one of Step S60 and Steps S35 and S50). Pattern data are acquired (one of Step S40 and Step S65). A positioning condition is computed based on image data that are generated at Step S15 (Step S20). The pattern data are corrected based on the computed positioning condition and on the acquired setting condition (Step S70). A partial pattern is sewn in accordance with the corrected pattern data (Step S80).
Patent EP-2292858-A2 (EP)
Inventor: BAI BAOKUN
IPC: E06B3/54
Filed: 2010-09-06
Abstract: A fastening device for curtain wall units includes a first clamping plate, a second clamping plate fixed to the first clamping plate and spaced apart from the first clamping plate, a first support plate positioned between the first clamping plate and the second clamping plate, and a second support plate hinged to the first support plate and configured to support the curtain wall units.
Patent EP-2311876-A2 (EP)
Inventor: KAVANAUGH WILLIAM MICHAEL
IPC: A61K39/395
Filed: 2006-07-27
Abstract: M-CSF-specific RXl-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in or remodeling in a subject afflicted with an osteoblastic or osteolytic disease.
Patent EP-2286848-A2 (EP)
Inventor: FALOTICO ROBERT
IPC: A61P41/00
Filed: 2005-01-19
Abstract: Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices.
Patent EP-2311363-A2 (EP)
Inventor: GROLL HUBERT
IPC: A47L15/46
Filed: 2010-09-30
Abstract: The appliance has a monitoring device (6) for monitoring a filling level (FS) of a rinse agent container (4) that stores consumables e.g. rinse agent (KS). The monitoring device determines number of residual rinse cycles (AS) for which the filling level of the container is sufficient for the rinse cycle. The monitoring device is coupled with a display device (7) e.g. LED, for displaying number of the rinse cycle. The monitoring device has a sensor, and outputs a warning message during dropping of the filling level of the consumables in the container.
Patent EP-2314268-A2 (EP)
Inventor: PERRY MATTHEW J
IPC: F16L37/56
Filed: 2005-02-23
Abstract: A compression treatment system (10) is provided that includes a first bladder (46a, 46b, 46c, 48a, 48b, 48c) supported about a limb. A second bladder is supported about the limb. The bladders are in fluid communication with a fluid source (50) and the bladders are inflated such that the first bladder is inflated for a first time period and the second bladder is inflated for a second time period. The second time period is initiated within the first time period. A single pressure sensor communicates with the first bladder and the second bladder.
Patent EP-2319999-A2 (EP)
Inventor: LAURENZIS DIRK
IPC: E04B2/96
Filed: 2010-10-12
Abstract: The facade element has framework elements, where a connecting device is provided between the framework elements. The framework elements have profiles (12,24). The profile of the former framework element and another profile of another framework element are arranged next to each in blocked condition.
Patent EP-2328116-A2 (EP)
Inventor: FURIHATA HIDEKI
IPC: G06K13/16
Filed: 2010-11-11
Abstract: A head 10, 12, 14 performs recording or reading information with respect to a sheet-shaped recording medium. A pair of rollers 11, 13 sandwich therebetween and transport the recording medium in a transport path of the recording medium passing through the head. A cantilevered frame 18 extends while being cantilevered in a direction traversing the transport path. One end of an opening and closing unit 3 is rotatably supported by the cantilevered frame 18. The opening and closing unit 3 is revolvable around the one end to move between a closed position where the opening and closing unit 3 covers at least a transport portion by the pair of rollers 11, 13 in the transport path and an open position where the transport position is exposed to the outside.
Patent EP-2238930-A2 (EP)
Title: Surgical access device  with one time seal
Inventor: WIDENHOUSE CHRISTOPHER W
IPC: A61B17/34
Filed: 2010-04-08
Abstract: Various methods and devices are provided for sealing a working channel of a surgical access device using a non-resealable membrane. The non-resealable membrane seals the working channel of the device before use and is punctured when a surgical instrument is inserted into the device such that it will no longer provide a seal in the working channel.
Patent EP-2359909-A2 (EP)
Inventor: DALY SUSAN
IPC: A61K8/19
Filed: 2010-12-13
Abstract: This invention relates to methods and kits for selectively depositing a treatment agent on hair without depositing the treatment agent on the skin. The method involves sequentially treating the hair with a cationic compound selected from cationic peptides, cationic proteins, cationic polymers, cationic dyes, cationic pigments, or mixtures of these in a composition with a pH from about 3 to about 6, followed by treatment with an anionic treatment compound selected from anionic particles, polymers, proteins, peptides, dyes, or mixtures of these in a composition with a pH of from about 5.5 to about 12. By this method, the treatment agent becomes deposited on the hair; however, any skin that is also contacted by the treatment compositions remains substantially untreated.
Patent EP-2410925-A2 (EP)
Title: Outil de montage pour dispositif anastomotique
Inventor: GROENBERG ANDERS
IPC: A61B17/11
Filed: 2010-03-18
Abstract: La présente invention concerne un outil de montage destiné au montage d'une partie annulaire flexible d'un dispositif anastomotique sur une partie rigide d'un dispositif anastomotique. Ledit outil comprend une partie d'accueil (104) située dans l'extrémité distale de l'outil de montage, destinée à accueillir ladite partie flexible à cet emplacement, et une partie de poignée (103) située proximalement à ladite partie d'accueil (104). Ladite partie d'accueil (104) comprend un élément de feuille tubulaire allongé (101), et un élément de déplacement tubulaire (201) disposé dans ledit élément de feuille (101) pour pouvoir être déplacé longitudinalement par rapport à l'élément de feuille (101), de telle sorte qu'une tablette (401) soit obtenue circonférentiellement à l'élément de déplacement tubulaire (106) et distalement à l'élément de feuille (101). Ladite tablette (401) est conçue pour accueillir la partie flexible. L'invention porte en outre sur un outil de montage destiné à accueillir une partie annulaire flexible d'un dispositif anastomotique sur une partie rigide d'un dispositif anastomotique. Ledit outil comprend un élément de guidage longitudinal (801) destiné à passer à travers un passage central ou une lumière dans un outil de montage selon les conditions ci-dessus, et une plaque de raccordement (802) disposée distalement sur l'élément de guidage (801). Ladite plaque de raccordement (802) est conçue pour être reliée à une partie rigide d'un dispositif anastomotique. L'invention porte également sur un kit afférent.
Patent EP-2403391-A2 (EP)
Title: Système de vérification et dispositif de mesure du rendement du nettoyage pour machine laveuse-sécheuse de sols
Inventor: CAGNA E
IPC: A47L11/40
Filed: 2010-03-01
Abstract: La présente invention concerne un système de vérification destiné au rendement du nettoyage d'une machine de travail dans le domaine du nettoyage, et concerne particulièrement une machine laveuse-sécheuse de sols (10) comprenant un dispositif de mesure dudit rendement du nettoyage et au moins un dispositif de transduction d'un paramètre cinématique de la machine, ledit dispositif permettant d'acquérir ledit paramètre cinématique en temps réel et de calculer, sur la base dudit et d'autres paramètres pouvant être entrés dans ledit dispositif à l'aide d'une interface utilisateur appropriée, la valeur correspondant au rendement courant de la machine laveuse-sécheuse.
Patent EP-2414841-A2 (EP)
Title: Diagnostic de maladies auto-immunes provoquées par le gluten
Inventor: KORPONAY-SZABO ILMA
IPC: G01N33/573
Filed: 2010-04-01
Abstract: La présente invention concerne un diagnostic sélectif de maladies auto-immunes provoquées par le gluten à l'aide de dosages par liaison utilisant les principaux épitopes cœliaques présents sur les protéines de la famille des transglutaminases.
Patent EP-2427611-A2 (EP)
Inventor: HORNUNG WERNER
IPC: E04G9/08
Filed: 2010-04-23
Abstract: L'invention concerne un matériel auxiliaire de coffrage composé d'au moins une nappe pouvant être fixée sur la surface intérieure d'un coffrage ou d'un élément de coffrage au moyen d'une colle auto-adhésive, la colle étant appliquée sur la face arrière de la nappe en couches partielles et/ou sous forme de points de colle espacés les uns des autres.
Patent EP-2456481-A2 (EP)
Title: Dispositifs médicaux ayant une couche de revêtement inorganique formée par dépôt de couches atomiques
Inventor: FLANAGAN AIDEN
IPC: A61L31/08
Filed: 2010-07-08
Abstract: L'invention concerne des dispositifs médicaux ayant un revêtement comprenant une ou plusieurs couches de revêtement inorganiques. La couche de revêtement inorganique peut être formée par un procédé de dépôt autolimité, tel que le dépôt de couches atomiques. La couche de revêtement inorganique peut avoir une épaisseur de moins de 30 nm. La couche de revêtement inorganique peut également être utilisée en association avec un agent thérapeutique comme barrière à libération contrôlée. La couche de revêtement inorganique peut avoir plusieurs propriétés souhaitées, notamment, par exemple, une résistance au craquage ou au délaminage, un haut degré d'uniformité, un haut degré de conformalité et/ou une compatibilité avec de faibles températures de dépôt.
Patent EP-2396389-A2 (EP)
Title: Système à alimentation centrale
Inventor: LAH RUBEN
IPC: B01J4/00
Filed: 2010-02-11
Abstract: La présente invention concerne un système à alimentation centrale destiné à être utilisé dans un système de cokéfaction différée, ou tout autre système similaire. Le système à alimentation centrale comprend un manchon d'entrée qui engage par coulissement une buse rétractable, avec un orifice d'entrée et un orifice de sortie, en connexion fluidique avec une source d'alimentation de produit intermédiaire résiduel, permettant au produit intermédiaire résiduel de s'écouler de la source d'alimentation à l'intérieur d'une cuve, réalisant ou induisant ainsi une distribution thermique homogène dans la cuve.